Table:
begin	end	state
1	27	cytoplasmic
28	50	transmembrane
51	64	non-cytoplasmic
65	87	transmembrane
88	93	cytoplasmic
94	114	transmembrane
115	119	non-cytoplasmic
120	145	transmembrane
146	164	cytoplasmic
165	185	transmembrane
186	210	non-cytoplasmic
211	230	transmembrane
231	256	cytoplasmic
257	279	transmembrane
280	298	non-cytoplasmic
299	318	transmembrane
319	324	cytoplasmic
325	342	transmembrane
343	347	non-cytoplasmic
348	371	transmembrane
372	382	cytoplasmic
383	402	transmembrane
403	407	non-cytoplasmic
408	428	transmembrane
429	442	cytoplasmic

Input:
>N515DRAFT_1918
MAFAAPPAPSKTSLPGAARERYTDYPMAMGVLTSIFFMWGFLTCLNDILIPHLKAVFKLN
YAEAMLVQFTFFGAYFLMSLPAGLLVARLGYKKGIVAGLAVAGVGAAGFWPAAAMHFYPA
FLGALFVLATGITVLQVAANAYVALLGPEKSASSRLTLAQALNSLGTFLAPKFGGLLILS
AAVLSAEQIAKLSPAEQVAYRVQEAQTVQGPYLGLAIVLFLLAVFVYLFRLPALTEKTEQ
ASVKQHSLVSPLRHPHVLFGVLAIFFYVGGEVAIGSFLVNYLSMPDIGNMSEQAAANWVA
YYWLGAMIGRFIGSALLAKLSPRKLLAIFAAINMALVLTTMMTKGTVAMYSVVSIGLFNS
IMFPTIFSLGIERMGPMTGEASSLLIMAIVGGAIVPFVQGLFADHIGVQHAFFLPLLCYA
YIVFYGLYGSRIKSDTPVAATH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server